- Home
- JANX vs SEM Comparison
JANX vs SEM Comparison
Compare JANX & SEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- SEM
- Stock Information
- Founded
- JANX 2017
- SEM 1996
- Country
- JANX United States
- SEM United States
- Employees
- JANX N/A
- SEM N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- SEM Hospital/Nursing Management
- Sector
- JANX Health Care
- SEM Health Care
- Exchange
- JANX Nasdaq
- SEM Nasdaq
- Market Cap
- JANX 1.4B
- SEM 1.6B
- IPO Year
- JANX 2021
- SEM 2009
- Fundamental
- Price
- JANX $27.01
- SEM $13.82
- Analyst Decision
- JANX Strong Buy
- SEM Buy
- Analyst Count
- JANX 11
- SEM 4
- Target Price
- JANX $76.55
- SEM $16.33
- AVG Volume (30 Days)
- JANX 927.5K
- SEM 1.2M
- Earning Date
- JANX 11-05-2025
- SEM 10-30-2025
- Dividend Yield
- JANX N/A
- SEM 1.81%
- EPS Growth
- JANX N/A
- SEM N/A
- EPS
- JANX N/A
- SEM 1.08
- Revenue
- JANX $439,000.00
- SEM $5,276,897,000.00
- Revenue This Year
- JANX N/A
- SEM $4.99
- Revenue Next Year
- JANX $91.66
- SEM $5.07
- P/E Ratio
- JANX N/A
- SEM $12.79
- Revenue Growth
- JANX N/A
- SEM 29.04
- 52 Week Low
- JANX $21.73
- SEM $11.65
- 52 Week High
- JANX $71.71
- SEM $40.98
- Technical
- Relative Strength Index (RSI)
- JANX 59.54
- SEM 59.67
- Support Level
- JANX $25.62
- SEM $13.25
- Resistance Level
- JANX $27.70
- SEM $13.67
- Average True Range (ATR)
- JANX 1.56
- SEM 0.43
- MACD
- JANX 0.30
- SEM 0.06
- Stochastic Oscillator
- JANX 69.68
- SEM 40.73
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About SEM Select Medical Holdings Corporation
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.